{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:20:54Z","timestamp":1790065254764,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Retinal ischemia is a major cause of visual impairment and blindness and is involved in various disorders including diabetic retinopathy, glaucoma, optic neuropathies and retinopathy of prematurity. Neurovascular degeneration is a common feature of these pathologies. Our lab has previously reported that the ureahydrolase arginase 2 (A2) is involved in ischemic retinopathies. Here, we are introducing A2 as a therapeutic target to prevent neurovascular injury after retinal ischemia\/reperfusion (I\/R) insult. Studies were performed with mice lacking both copies of A2 (A2<jats:sup>\u2212\/\u2212<\/jats:sup>) and wild-type (WT) controls (C57BL6J). I\/R insult was conducted on the right eye and the left eye was used as control. Retinas were collected for analysis at different times (3\u2009h\u20134 week after injury). Neuronal and microvascular degeneration were evaluated using NeuN staining and vascular digests, respectively. Glial activation was evaluated by glial fibrillary acidic protein expression. Necrotic cell death was studied by propidium iodide labeling and western blot for RIP-3. Arginase expression was determined by western blot and quantitative RT-PCR. Retinal function was determined by electroretinography (ERG). A2 mRNA and protein levels were increased in WT I\/R. A2 deletion significantly reduced ganglion cell loss and microvascular degeneration and preserved retinal morphology after I\/R. Glial activation, reactive oxygen species formation and cell death by necroptosis were significantly reduced by A2 deletion. ERG showed improved positive scotopic threshold response with A2 deletion. This study shows for the first time that neurovascular injury after retinal I\/R is mediated through increased expression of A2. Deletion of A2 was found to be beneficial in reducing neurovascular degeneration after I\/R.<\/jats:p>","DOI":"10.1038\/cddis.2016.295","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T13:51:34Z","timestamp":1479995494000},"page":"e2483-e2483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Arginase 2 promotes neurovascular degeneration during ischemia\/reperfusion injury"],"prefix":"10.1038","volume":"7","author":[{"given":"Esraa","family":"Shosha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumasa","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modesto","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R William","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth B","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Priya","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"key":"BFcddis2016295_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.preteyeres.2015.05.001","volume":"48","author":"RA Kowluru","year":"2015","unstructured":"Kowluru RA, Kowluru A, Mishra M, Kumar B . Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res 2015; 48: 40\u201361.","journal-title":"Prog Retin Eye Res"},{"key":"BFcddis2016295_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","volume":"122","author":"ME Hartnett","year":"2015","unstructured":"Hartnett ME . Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 2015; 122: 200\u2013210.","journal-title":"Ophthalmology"},{"key":"BFcddis2016295_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2217\/imt.11.24","volume":"3","author":"W Zhang","year":"2011","unstructured":"Zhang W, Liu H, Rojas M, Caldwell RW, Caldwell RB . Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy 2011; 3: 609\u2013628.","journal-title":"Immunotherapy"},{"key":"BFcddis2016295_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","volume":"23","author":"NN Osborne","year":"2004","unstructured":"Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J . Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004; 23: 91\u2013147.","journal-title":"Prog Retin Eye Res"},{"key":"BFcddis2016295_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","volume":"43","author":"N Cuenca","year":"2014","unstructured":"Cuenca N, Fernandez-Sanchez L, Campello L, Maneu V, De la Villa P, Lax P et al. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res 2014; 43: 17\u201375.","journal-title":"Prog Retin Eye Res"},{"key":"BFcddis2016295_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/cne.21449","volume":"504","author":"LE Downie","year":"2007","unstructured":"Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL . Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity. J Comp Neurol 2007; 504: 404\u2013417.","journal-title":"J Comp Neurol"},{"key":"BFcddis2016295_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1167\/iovs.06-0510","volume":"48","author":"L Zheng","year":"2007","unstructured":"Zheng L, Gong B, Hatala DA, Kern TS . Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci 2007; 48: 361\u2013367.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR8","doi-asserted-by":"publisher","first-page":"e23194","DOI":"10.1371\/journal.pone.0023194","volume":"6","author":"L Wang","year":"2011","unstructured":"Wang L, Li C, Guo H, Kern TS, Huang K, Zheng L . Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury. PLoS One 2011; 6: e23194.","journal-title":"PLoS One"},{"key":"BFcddis2016295_CR9","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1167\/iovs.10-5264","volume":"51","author":"SF Abcouwer","year":"2010","unstructured":"Abcouwer SF, Lin CM, Wolpert EB, Shanmugam S, Schaefer EW, Freeman WM et al. Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2010; 51: 5920\u20135933.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR10","first-page":"2132","volume":"39","author":"DM Rosenbaum","year":"1998","unstructured":"Rosenbaum DM, Rosenbaum PS, Gupta H, Singh M, Aggarwal A, Hall DH et al. The role of the p53 protein in the selective vulnerability of the inner retina to transient ischemia. Invest Ophthalmol Vis Sci 1998; 39: 2132\u20132139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR11","doi-asserted-by":"publisher","first-page":"8123","DOI":"10.1167\/iovs.11-8318","volume":"52","author":"H Yokota","year":"2011","unstructured":"Yokota H, Narayanan SP, Zhang W, Liu H, Rojas M, Xu Z et al. Neuroprotection from retinal ischemia\/reperfusion injury by NOX2 NADPH oxidase deletion. Invest Ophthalmol Vis Sci 2011; 52: 8123\u20138131.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fimmu.2013.00173","volume":"4","author":"C Patel","year":"2013","unstructured":"Patel C, Rojas M, Narayanan SP, Zhang W, Xu Z, Lemtalsi T et al. Arginase as a mediator of diabetic retinopathy. Front Immunol 2013; 4: 173.","journal-title":"Front Immunol"},{"key":"BFcddis2016295_CR13","doi-asserted-by":"publisher","first-page":"e22460","DOI":"10.1371\/journal.pone.0022460","volume":"6","author":"SP Narayanan","year":"2011","unstructured":"Narayanan SP, Suwanpradid J, Saul A, Xu Z, Still A, Caldwell RW et al. Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity. PLoS One 2011; 6: e22460.","journal-title":"PLoS One"},{"key":"BFcddis2016295_CR14","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1038\/cddis.2014.23","volume":"5","author":"SP Narayanan","year":"2014","unstructured":"Narayanan SP, Xu Z, Putluri N, Sreekumar A, Lemtalsi T, Caldwell RW et al. Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism. Cell Death Dis 2014; 5: e1075.","journal-title":"Cell Death Dis"},{"key":"BFcddis2016295_CR15","doi-asserted-by":"publisher","first-page":"e110604","DOI":"10.1371\/journal.pone.0110604","volume":"9","author":"J Suwanpradid","year":"2014","unstructured":"Suwanpradid J, Rojas M, Behzadian MA, Caldwell RW, Caldwell RB . Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration. PLoS One 2014; 9: e110604.","journal-title":"PLoS One"},{"key":"BFcddis2016295_CR16","first-page":"407","volume":"37","author":"DE Ash","year":"2000","unstructured":"Ash DE, Cox JD, Christianson DW . Arginase: a binuclear manganese metalloenzyme. Met Ions Biol Syst 2000; 37: 407\u2013428.","journal-title":"Met Ions Biol Syst"},{"key":"BFcddis2016295_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.nutr.22.110801.140547","volume":"22","author":"SM Morris Jr","year":"2002","unstructured":"Morris SM Jr . Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 2002; 22: 87\u2013105.","journal-title":"Annu Rev Nutr"},{"key":"BFcddis2016295_CR18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1023\/A:1003468726969","volume":"30","author":"K Miyanaka","year":"1998","unstructured":"Miyanaka K, Gotoh T, Nagasaki A, Takeya M, Ozaki M, Iwase K et al. Immunohistochemical localization of arginase II and other enzymes of arginine metabolism in rat kidney and liver. Histochem J 1998; 30: 741\u2013751.","journal-title":"Histochem J"},{"key":"BFcddis2016295_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.preteyeres.2013.06.002","volume":"36","author":"SP Narayanan","year":"2013","unstructured":"Narayanan SP, Rojas M, Suwanpradid J, Toque HA, Caldwell RW, Caldwell RB . Arginase in retinopathy. Prog Retin Eye Res 2013; 36: 260\u2013280.","journal-title":"Prog Retin Eye Res"},{"key":"BFcddis2016295_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tips.2015.03.006","volume":"36","author":"RB Caldwell","year":"2015","unstructured":"Caldwell RB, Toque HA, Narayanan SP, Caldwell RW . Arginase: an old enzyme with new tricks. Trends Pharmacol Sci 2015; 36: 395\u2013405.","journal-title":"Trends Pharmacol Sci"},{"key":"BFcddis2016295_CR21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1440-1681.2007.04638.x","volume":"34","author":"W Durante","year":"2007","unstructured":"Durante W, Johnson FK, Johnson RA . Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007; 34: 906\u2013911.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFcddis2016295_CR22","doi-asserted-by":"publisher","first-page":"H159","DOI":"10.1152\/ajpheart.00774.2011","volume":"302","author":"MJ Romero","year":"2012","unstructured":"Romero MJ, Iddings JA, Platt DH, Ali MI, Cederbaum SD, Stepp DW et al. Diabetes-induced vascular dysfunction involves arginase I. Am J Physiol Heart Circ Physiol 2012; 302: H159\u2013H166.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFcddis2016295_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/CIRCRESAHA.107.155028","volume":"102","author":"MJ Romero","year":"2008","unstructured":"Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008; 102: 95\u2013102.","journal-title":"Circ Res"},{"key":"BFcddis2016295_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.phrs.2004.04.005","volume":"50","author":"H Erbas","year":"2004","unstructured":"Erbas H, Aydogdu N, Kaymak K . Effects of N-acetylcysteine on arginase, ornithine and nitric oxide in renal ischemia-reperfusion injury. Pharmacol Res 2004; 50: 523\u2013527.","journal-title":"Pharmacol Res"},{"key":"BFcddis2016295_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/cvr\/cvp303","volume":"85","author":"C Jung","year":"2010","unstructured":"Jung C, Gonon AT, Sjoquist PO, Lundberg JO, Pernow J . Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res 2010; 85: 147\u2013154.","journal-title":"Cardiovasc Res"},{"key":"BFcddis2016295_CR26","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/00007890-199506000-00007","volume":"59","author":"F Langle","year":"1995","unstructured":"Langle F, Roth E, Steininger R, Winkler S, Muhlbacher F . Arginase release following liver reperfusion. Evidence of hemodynamic action of arginase infusions. Transplantation 1995; 59: 1542\u20131549.","journal-title":"Transplantation"},{"key":"BFcddis2016295_CR27","doi-asserted-by":"publisher","first-page":"G512","DOI":"10.1152\/ajpgi.00227.2006","volume":"292","author":"KM Reid","year":"2007","unstructured":"Reid KM, Tsung A, Kaizu T, Jeyabalan G, Ikeda A, Shao L et al. Liver I\/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA). Am J Physiol Gastrointest Liver Physiol 2007; 292: G512\u2013G517.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFcddis2016295_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/apha.12097","volume":"208","author":"J Gronros","year":"2013","unstructured":"Gronros J, Kiss A, Palmer M, Jung C, Berkowitz D, Pernow J . Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model. Acta Physiol (Oxf) 2013; 208: 172\u2013179.","journal-title":"Acta Physiol (Oxf)"},{"key":"BFcddis2016295_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2013.04.044","volume":"712","author":"Y Tratsiakovich","year":"2013","unstructured":"Tratsiakovich Y, Gonon AT, Krook A, Yang J, Shemyakin A, Sjoquist PO et al. Arginase inhibition reduces infarct size via nitric oxide, protein kinase C epsilon and mitochondrial ATP-dependent K+ channels. Eur J Pharmacol 2013; 712: 16\u201321.","journal-title":"Eur J Pharmacol"},{"key":"BFcddis2016295_CR30","doi-asserted-by":"publisher","first-page":"e103260","DOI":"10.1371\/journal.pone.0103260","volume":"9","author":"O Kovamees","year":"2014","unstructured":"Kovamees O, Shemyakin A, Pernow J . Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus. PLoS One 2014; 9: e103260.","journal-title":"PLoS One"},{"key":"BFcddis2016295_CR31","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1523\/JNEUROSCI.4668-14.2015","volume":"35","author":"MJ Kan","year":"2015","unstructured":"Kan MJ, Lee JE, Wilson JG, Everhart AL, Brown CM, Hoofnagle AN et al. Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease. J Neurosci 2015; 35: 5969\u20135982.","journal-title":"J Neurosci"},{"key":"BFcddis2016295_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3858\/emm.2012.44.10.068","volume":"44","author":"WS Shin","year":"2012","unstructured":"Shin WS, Berkowitz DE, Ryoo SW . Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice. Exp Mol Med 2012; 44: 594\u2013602.","journal-title":"Exp Mol Med"},{"key":"BFcddis2016295_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-014-0113-z","volume":"13","author":"Y Yu","year":"2014","unstructured":"Yu Y, Rajapakse AG, Montani JP, Yang Z, Ming XF . p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-Uncoupling in Obesity. Cardiovasc Diabetol 2014; 13: 113.","journal-title":"Cardiovasc Diabetol"},{"key":"BFcddis2016295_CR34","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/jcbfm.2010.47","volume":"30","author":"BR Bitner","year":"2010","unstructured":"Bitner BR, Brink DC, Mathew LC, Pautler RG, Robertson CS . Impact of arginase II on CBF in experimental cortical impact injury in mice using MRI. J Cereb Blood Flow Metab 2010; 30: 1105\u20131109.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFcddis2016295_CR35","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1167\/iovs.13-13372","volume":"55","author":"H Schmid","year":"2014","unstructured":"Schmid H, Renner M, Dick HB, Joachim SC . Loss of inner retinal neurons after retinal ischemia in rats. Invest Ophthalmol Vis Sci 2014; 55: 2777\u20132787.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR36","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/jnr.22314","volume":"88","author":"DM Rosenbaum","year":"2010","unstructured":"Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 2010; 88: 1569\u20131576.","journal-title":"J Neurosci Res"},{"key":"BFcddis2016295_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2014.04.009","volume":"123","author":"G Dvoriantchikova","year":"2014","unstructured":"Dvoriantchikova G, Degterev A, Ivanov D . Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage. Exp Eye Res 2014; 123: 1\u20137.","journal-title":"Exp Eye Res"},{"key":"BFcddis2016295_CR38","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1101\/gad.223321.113","volume":"27","author":"K Moriwaki","year":"2013","unstructured":"Moriwaki K, Chan FK . RIP3: a molecular switch for necrosis and inflammation. Genes Dev 2013; 27: 1640\u20131649.","journal-title":"Genes Dev"},{"key":"BFcddis2016295_CR39","first-page":"967","volume":"40","author":"TT Lam","year":"1999","unstructured":"Lam TT, Abler AS, Tso MO . Apoptosis and caspases after ischemia-reperfusion injury in rat retina. Invest Ophthalmol Vis Sci 1999; 40: 967\u2013975.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR40","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/archopht.1992.01080180134041","volume":"110","author":"K Takahashi","year":"1992","unstructured":"Takahashi K, Lam TT, Edward DP, Buchi ER, Tso MO . Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol 1992; 110: 862\u2013870.","journal-title":"Arch Ophthalmol"},{"key":"BFcddis2016295_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0074-7696(03)30005-1","volume":"230","author":"GP Lewis","year":"2003","unstructured":"Lewis GP, Fisher SK . Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol 2003; 230: 263\u2013290.","journal-title":"Int Rev Cytol"},{"key":"BFcddis2016295_CR42","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1073\/pnas.0501719102","volume":"102","author":"H Zhao","year":"2005","unstructured":"Zhao H, Joseph J, Fales HM, Sokoloski EA, Levine RL, Vasquez-Vivar J et al. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc Natl Acad Sci USA 2005; 102: 5727\u20135732.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 3","key":"BFcddis2016295_CR43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1113\/jphysiol.2002.019703","volume":"543","author":"SM Saszik","year":"2002","unstructured":"Saszik SM, Robson JG, Frishman LJ . The scotopic threshold response of the dark-adapted electroretinogram of the mouse. J Physiol 2002; 543 (Pt 3): 899\u2013916.","journal-title":"J Physiol"},{"key":"BFcddis2016295_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1476-5381.2011.01584.x","volume":"165","author":"S Chandra","year":"2012","unstructured":"Chandra S, Romero MJ, Shatanawi A, Alkilany AM, Caldwell RB, Caldwell RW . Oxidative species increase arginase activity in endothelial cells through the RhoA\/Rho kinase pathway. Br J Pharmacol 2012; 165: 506\u2013519.","journal-title":"Br J Pharmacol"},{"key":"BFcddis2016295_CR45","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1111\/bph.13242","volume":"172","author":"J Pernow","year":"2015","unstructured":"Pernow J, Kiss A, Tratsiakovich Y, Climent B . Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus. Br J Pharmacol 2015; 172: 4684\u20134698.","journal-title":"Br J Pharmacol"},{"key":"BFcddis2016295_CR46","doi-asserted-by":"publisher","first-page":"32197","DOI":"10.1074\/jbc.M605237200","volume":"281","author":"C Marathe","year":"2006","unstructured":"Marathe C, Bradley MN, Hong C, Lopez F, Ruiz de Galarreta CM, Tontonoz P et al. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem 2006; 281: 32197\u201332206.","journal-title":"J Biol Chem"},{"key":"BFcddis2016295_CR47","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s00125-012-2789-5","volume":"56","author":"SC Elms","year":"2013","unstructured":"Elms SC, Toque HA, Rojas M, Xu Z, Caldwell RW, Caldwell RB . The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes. Diabetologia 2013; 56: 654\u2013662.","journal-title":"Diabetologia"},{"key":"BFcddis2016295_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2011.04.026","volume":"51","author":"Y Wei","year":"2011","unstructured":"Wei Y, Gong J, Yoshida T, Eberhart CG, Xu Z, Kombairaju P et al. Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. Free Radic Biol Med 2011; 51: 216\u2013224.","journal-title":"Free Radic Biol Med"},{"key":"BFcddis2016295_CR49","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1167\/iovs.09-3633","volume":"50","author":"B Chen","year":"2009","unstructured":"Chen B, Caballero S, Seo S, Grant MB, Lewin AS . Delivery of antioxidant enzyme genes to protect against ischemia\/reperfusion-induced injury to retinal microvasculature. Invest Ophthalmol Vis Sci 2009; 50: 5587\u20135595.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jnc.13064","volume":"133","author":"Z Xu","year":"2015","unstructured":"Xu Z, Cho H, Hartsock MJ, Mitchell KL, Gong J, Wu L et al. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion. J Neurochem 2015; 133: 233\u2013241.","journal-title":"J Neurochem"},{"key":"BFcddis2016295_CR51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20090598","volume":"421","author":"RA Casero","year":"2009","unstructured":"Casero RA, Pegg AE . Polyamine catabolism and disease. Biochem J 2009; 421: 323\u2013338.","journal-title":"Biochem J"},{"key":"BFcddis2016295_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.brainres.2011.06.005","volume":"1403","author":"KJ Cho","year":"2011","unstructured":"Cho KJ, Kim JH, Park HY, Park CK . Glial cell response and iNOS expression in the optic nerve head and retina of the rat following acute high IOP ischemia-reperfusion. Brain Res 2011; 1403: 67\u201377.","journal-title":"Brain Res"},{"key":"BFcddis2016295_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1017\/S0952523800173122","volume":"17","author":"XX Zeng","year":"2000","unstructured":"Zeng XX, Ng YK, Ling EA . Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 2000; 17: 463\u2013471.","journal-title":"Vis Neurosci"},{"key":"BFcddis2016295_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2202-14-16","volume":"14","author":"JF Huang","year":"2013","unstructured":"Huang JF, Shang L, Zhang MQ, Wang H, Chen D, Tong JB et al. Differential neuronal expression of receptor interacting protein 3 in rat retina: involvement in ischemic stress response. BMC Neurosci 2013; 14: 16.","journal-title":"BMC Neurosci"},{"key":"BFcddis2016295_CR55","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1167\/iovs.04-0940","volume":"45","author":"T Da","year":"2004","unstructured":"Da T, Verkman AS . Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest Ophthalmol Vis Sci 2004; 45: 4477\u20134483.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR56","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1096\/fj.03-0115fje","volume":"17","author":"TW Hein","year":"2003","unstructured":"Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L . Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. Faseb J 2003; 17: 2328\u20132330.","journal-title":"Faseb J"},{"key":"BFcddis2016295_CR57","first-page":"3607","volume":"41","author":"H Shibuki","year":"2000","unstructured":"Shibuki H, Katai N, Yodoi J, Uchida K, Yoshimura N . Lipid peroxidation and peroxynitrite in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2000; 41: 3607\u20133614.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1167\/iovs.14-15447","volume":"56","author":"S Nashine","year":"2015","unstructured":"Nashine S, Liu Y, Kim BJ, Clark AF, Pang IH . Role of C\/EBP homologous protein in retinal ganglion cell death after ischemia\/reperfusion injury. Invest Ophthalmol Vis Sci 2015; 56: 221\u2013231.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcddis2016295_CR59","first-page":"e50489","volume":"76","author":"JC Chou","year":"2013","unstructured":"Chou JC, Rollins SD, Fawzi AA . Trypsin digest protocol to analyze the retinal vasculature of a mouse model. J Vis Exp 2013; 76: e50489.","journal-title":"J Vis Exp"},{"key":"BFcddis2016295_CR60","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/01.RES.82.12.1298","volume":"82","author":"FJ Miller Jr.","year":"1998","unstructured":"Miller FJ Jr., Gutterman DD, Rios CD, Heistad DD, Davidson BL . Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82: 1298\u20131305.","journal-title":"Circ Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2016295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016295","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T20:00:26Z","timestamp":1718913626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2016295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11]]}},"alternative-id":["BFcddis2016295"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.295","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]},"assertion":[{"value":"25 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}